HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

Drugmaker Seeks FDA Approval For Over-the-Counter Birth Control

WASHINGTON ( Associated Press) — For the first time, a pharmaceutical company has applied for permission to sell a birth control pill without a prescription in the United States. Monday’s HRA Pharma application sets a high-stakes decision for health regulators amid legal and political battles over […]

more info 08/03/2022View Related Articles
Bookmark and Share

New data from Phase III HAVEN 6 study reinforce favourable safety and efficacy profile of $RHHBY Hemlibra in people with moderate or mild haemophilia A

F. Hoffmann-La Roche Ltd Hemlibra continues to demonstrate clinically meaningful bleed control, with 66.7% of participants with moderate or mild haemophilia A experiencing zero treated bleeds at 55.6 weeks median follow-up [1] New data also reinforce Hemlibra’s favourable safety profile, with […]

more info 08/03/2022View Related Articles
Bookmark and Share

Pandemic Windfall Upends Status Quo For Top-10 Best-Selling Drugs

Now that the books for 2021 are closed, In Vivo has crunched the numbers and can report on the best-selling pharmaceuticals last year. And what a year it was, with expectations for drug launches having been completely rewritten. Humira lost its record for peak annual drug sales, not to Keytruda as […]

more info 08/03/2022View Related Articles
Bookmark and Share

OSE Immunotherapeutics Appoints Alexis Vandier as Chief Executive Officer

OSE Immunotherapeutics NANTES, France, July 13, 2022 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the appointment of Alexis Vandier as Chief Executive Officer, effective immediately. Alexis Vandier brings an impressive track record of […]

more info 08/03/2022View Related Articles
Bookmark and Share

$AGTC Announces Pricing of $10 Million Underwritten Public Offering

GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development and commercialization of adeno-associated virus […]

more info 08/03/2022View Related Articles
Bookmark and Share

Roche rings Bicycle bell again, grabbing another cancer target

Roche’s Genentech unit has gone all in on its collaboration with UK biotech Bicycle Therapeutics, taking up an option on a second additional target in the area of cancer immunotherapy. Bicycle’s bicyclic peptide drug discovery platform is designed to produce drug candidates that have […]

more info 08/03/2022View Related Articles
Bookmark and Share

Critical Contrast: Prelude Therapeutics (NASDAQ:PRLD) versus Vertex Pharmaceuticals (NASDAQ:VRTX)

Prelude Therapeutics ( NASDAQ:PRLD – Get Rating ) and Vertex Pharmaceuticals ( NASDAQ:VRTX – Get Rating ) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, […]

more info 08/03/2022View Related Articles
Bookmark and Share

Lower insulin co-pays, list prices targeted in new bipartisan U.S. Senate bill

5:38 News Story Lower insulin co-pays, list prices targeted in new bipartisan U.S. Senate bill Getty Images. WASHINGTON — Two key senators have unveiled the details of a bipartisan plan to lower costs for insulin, a lifesaving drug that some Americans have struggled to afford in recent years as […]

more info 08/03/2022View Related Articles
Bookmark and Share

Global API Manufacturing Industry is Expecting a Major Technological Makeover After COVID19 Impact

Global API Manufacturing Industry is Expecting a Major Technological Makeover After COVID19 Impact [Marketsandmarkets-New-HealthcareDomain] - Friday, July 1, 2022. Submitted by Nath Mayur . Major Objectives of This Study: # To define, describe, and forecast the global active pharmaceutical […]

more info 08/03/2022View Related Articles
Bookmark and Share

The Relationship Between Healthcare and Blockchain Technology

Blockchain technology has become an enormous trend across all industries, and not only because of its application for decentralized finance and apps. The nature of blockchain tech means that many business processes can be carried out securely, with transparency and data protection at its core, which […]

more info 08/03/2022View Related Articles
Bookmark and Share

Calling Them “Vanity Drugs,” Some Insurers Refuse to Cover New Anti-Obesity Drugs

In an interview with Pharmacy Times, Ron Lanton III, Esq., principal at Lanton Law, discussed why insurers are refusing to cover new, highly effective anti-obesity drugs and how some prescribers are getting around the issue. Lanton said that this is a common issue across many different disease […]

more info 08/03/2022View Related Articles
Bookmark and Share

A New Covid Vaccine That’s Effective Against Omicron Could Hit The Market This Year

Sanofi and GlaxoSmithKline are hoping to launch their latest Covid vaccine later this year after trials found it to be particularly effective against the omicron variant, promising news for the pharmaceutical giants as they push to make up lost ground and capture part of the maturing coronavirus […]

more info 08/03/2022View Related Articles
Bookmark and Share

Contract research organization Service Market Trends, Leading Key Players, Future Growth, Revenue, Demand Forecast, Applications 2021-2027

A comprehensive overview of the contract research organization services market is recently added by UnivDatos Market Insights to its humongous database. The contract research organization services market report has been aggregated by collecting informative data of various dynamics such as market […]

more info 08/03/2022View Related Articles
Bookmark and Share


Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

    No feed items found.

 
Syndicated Reports

Current and Future Analysis of Real World Data Market With New Business Strategies and Forecast by 2029 Parexel International Corporation, TriNetX LLC

Global Gene Therapy Report 2022-2031

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Economic & Related Consulting Service Revenues World Report & Database

 
White Papers

How Corporate Executives View Rising Health Care Cost and the Role of Government

Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a CAGR of 10%

Build or Buy – Which Is the Right QMS Choice for Your Company?

Finland – A treasure trove for real-world evidence (RWE) research and innovation

HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists